NIZORAL ANTI-DANDRUFF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nizoral Anti-dandruff, and what generic alternatives are available?
Nizoral Anti-dandruff is a drug marketed by Kramer and is included in one NDA.
The generic ingredient in NIZORAL ANTI-DANDRUFF is ketoconazole. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ketoconazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nizoral Anti-dandruff
A generic version of NIZORAL ANTI-DANDRUFF was approved as ketoconazole by TARO on June 15th, 1999.
Summary for NIZORAL ANTI-DANDRUFF
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Patent Applications: | 1,521 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NIZORAL ANTI-DANDRUFF at DailyMed |
Pharmacology for NIZORAL ANTI-DANDRUFF
Drug Class | Azole Antifungal |
Mechanism of Action | Cytochrome P450 3A4 Inhibitors Cytochrome P450 3A5 Inhibitors P-Glycoprotein Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for NIZORAL ANTI-DANDRUFF
US Patents and Regulatory Information for NIZORAL ANTI-DANDRUFF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kramer | NIZORAL ANTI-DANDRUFF | ketoconazole | SHAMPOO;TOPICAL | 020310-001 | Oct 10, 1997 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NIZORAL ANTI-DANDRUFF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Kramer | NIZORAL ANTI-DANDRUFF | ketoconazole | SHAMPOO;TOPICAL | 020310-001 | Oct 10, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Kramer | NIZORAL ANTI-DANDRUFF | ketoconazole | SHAMPOO;TOPICAL | 020310-001 | Oct 10, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Kramer | NIZORAL ANTI-DANDRUFF | ketoconazole | SHAMPOO;TOPICAL | 020310-001 | Oct 10, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for NIZORAL ANTI-DANDRUFF
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
HRA Pharma Rare Diseases | Ketoconazole HRA | ketoconazole | EMEA/H/C/003906 Ketoconazole HRA is indicated for the treatment of endogenous Cushing’s syndrome in adults and adolescents above the age of 12 years. |
Authorised | no | no | yes | 2014-11-18 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for NIZORAL ANTI-DANDRUFF
See the table below for patents covering NIZORAL ANTI-DANDRUFF around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
U.S.S.R. | 786899 | METHOD OF PREPARING DERIVATIVES OF 1-(1,3-DIOXOLAN-2-YL-METHYL)-1H-IMIDAZOLES OR -1H-1,2,4-TRIAZOLES OR THEIR ACID-ADDITIVE SALTS IN THE FORM OF MIXTURE OR INDIVIDUAL STEREOISOMERS | ⤷ Try a Trial |
Romania | 113608 | COMPOZITIE DE SAMPON DE PAR (HAIR SHAMPOO COMPOSITION) | ⤷ Try a Trial |
Japan | S5395973 | AZOLE DERIVATIVES | ⤷ Try a Trial |
Ireland | 780195 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |